BVL3572S
BVL3572S is a hydroxamic acid derivative with potent bactericidal activity against Mycobacterium tuberculosis (Mtb), exhibiting an MIC90 of 1.7 μM. It eradicates Mtb by inhibiting the pyridoxal phosphate (PLP) -dependent aminotransferases HisC and AlaA. BVL3572S is applicable in tuberculosis (TB) research.
Product Specifications
CAS Number
1258544-63-6
Smiles
ON1C=2C (C[C@H] (N) C1=O) =CC=C (Br) C2
Molecular Formula
C9H9BrN2O2
Molecular Weight
257.09
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
043296-AP 200 µL
TRPV2, NT (TRPV2, VRL, Transient receptor potential cation channel subfamily V member 2, Osm-9-like TRP channel 2, Vanilloid receptor-like protein 1) (AP) discontinued
Sign In for Pricing
View Details PC1008282-01 50 mg
4-Fluoro-6- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzo[d]thiazol-2-amine
Sign In for Pricing
View Details PC1008282-02 100 mg
4-Fluoro-6- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzo[d]thiazol-2-amine
Sign In for Pricing
View Details